PAPER Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A
SEARCH RESULTS
330988 RESULTS
PAPER Fennema-Notestine C, Panizzon MS, Thompson WR, Chen CH, Eyler LT, Fischl B, Franz CE, Grant MD, Jak AJ, Jernigan TL, Lyons MJ, Neale MC, Seidman LJ, Tsuang MT, Xian H, Dale AM, Kremen WS
Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.
J Alzheimers Dis. 2011;26 Suppl 3:49-60. PubMed: 21971450PAPER Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, Detoledo-Morrell L, Killiany RJ, Lehéricy S, Pantel J, Pruessner JC, Soininen H, Watson C, Duchesne S, Jack CR, Frisoni GB
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol.
J Alzheimers Dis. 2011;26 Suppl 3:61-75. PubMed: 21971451PAPER Tosun D, Schuff N, Shaw LM, Trojanowski JQ, Weiner MW,
Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.
J Alzheimers Dis. 2011;26 Suppl 3:77-90. PubMed: 21971452PAPER Kerchner GA
Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:91-5. PubMed: 21971453PAPER Weih M, Degirmenci U, Kreil S, Suttner G, Schmidt D, Kornhuber J, Lewczuk P, Kuwert T
Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:97-103. PubMed: 21971454PAPER Furst AJ, Lal RA
Amyloid-β and glucose metabolism in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:105-16. PubMed: 21971455PAPER Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V
Effects of hypoperfusion in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:123-33. PubMed: 21971457PAPER Jensen JR, Cisek K, Funk KE, Naphade S, Schafer KN, Kuret J
Research towards tau imaging.
J Alzheimers Dis. 2011;26 Suppl 3:147-57. PubMed: 21971459PAPER Shin J, Kepe V, Barrio JR, Small GW
The merits of FDDNP-PET imaging in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:135-45. PubMed: 21971458PAPER Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
J Alzheimers Dis. 2011;26 Suppl 3:159-99. PubMed: 21971460PAPER Babiloni C, Vecchio F, Lizio R, Ferri R, Rodriguez G, Marzano N, Frisoni GB, Rossini PM
Resting state cortical rhythms in mild cognitive impairment and Alzheimer's disease: electroencephalographic evidence.
J Alzheimers Dis. 2011;26 Suppl 3:201-14. PubMed: 21971461PAPER Olichney JM, Yang JC, Taylor J, Kutas M
Cognitive event-related potentials: biomarkers of synaptic dysfunction across the stages of Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:215-28. PubMed: 21971462PAPER Ashford JW, Coburn KL, Rose TL, Bayley PJ
P300 energy loss in aging and Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:229-38. PubMed: 21971463PAPER Verdoorn TA, McCarten JR, Arcienegas DB, Golden R, Moldauer L, Georgopoulos A, Lewis S, Cassano M, Hemmy L, Orr W, Rojas DC
Evaluation and tracking of Alzheimer's disease severity using resting-state magnetoencephalography.
J Alzheimers Dis. 2011;26 Suppl 3:239-55. PubMed: 21971464Current Filters
No filters selected